same heat-labile cytotoxic material found in patients with clindamycin-associated pseudomembranous colitis could be found in hamsters receiving clindamycin.gJO The cytotoxic effect could be neutralized by antiserum against Clostridium difficile and Clostridium sordellii, but not by specific antisera against other Clostridium species. Finally, the same cytotoxic activity was demonstrated in broth culture filtrates of C difficile strains isolated from patients with antibiotic-associated colitis. Thus, most cases of antibiotic-associated pseudomembranous colitis are now associated with cytotoxigenic C difficile.ll C difficile was first described in 1935 by Hall and O'Toole,12 who found this anaerobic bacillus colonizing newborns. This microogranism was initially named Bacillus difficilis because of the difficulties encountered in growing this anaerobe in cultures. Although only a colonizer of newborns, this organism was noted to be pathogenic for guinea pigs and rabbits. Snyder, in 1937, noted that certain strains of B difficilis produced a thermolabile toxin that was lethal for guinea pigs and that the guinea pigs could be protected with specific antiserum. 13 Pseudomembranous enterocolitis has been associated with a number of antibiotics besides clindamycin.14 In addition, case clusters15 suggest C difficile spores16 may transmit this illness in the nosocomial setting. l7 In this issue of Infection Control and Hospital Epidemiology, Brown and colleagues report a loo-fold increase in the hospital-wide attack rate for C difficile colitis over a five-year span. Risk factors included the use of antibiotics, older age, hospitalization in an intensive care unit and nonsurgical gastrointestinal manipulation. The association with antibiotic use implicated both clindamycin and third-generation cephalosporins. The former agent is well-known for its association with antibiotic-induced colitis; the third-generation cephalosporins, on the other hand, are not, and would not be suspected at first glance because of their minimal activity against anaerobic organisms.
It should be realized that the third-generation cephalosporins do have activity against many anaerobes other than those in the Bacteroides fiagilis group. CeRriaxone is largely excreted via the biliary tract and could easily alter the gastrointestinal flora. CeRizoxime has been reported to have activity similar to that of cefoxitin against members of the B fragilis grou~.~~ These two agents, plus ceftazidime, were implicated along with clindamycin in the study by Brown, et al. This study did not investigate the potential role of nosocomial transmission in the increase in colitis, but others17 have demonstrated the importance of nosocomial acquisition of C difficile colitis.
The study does point out the explosive potential for C difficile colitis in the hospital setting, Recognition of this potential and appropriate screening should be included in infection control programs at other hospitals. This increase in colitis was controlled by restricting clindamycin use and encouraging metronidazole use. These control measures, plus the recommendation of early isolation of infected patients, are prudent and should be considered by infection control committees in other hospitals. In this DRG era, the increased morbidity and costs associated with a lOO-fold increase in C difficile colitis is something no hospital can afford.
